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ABSTRACT 
Recent studies in Western nations have found inverse associations of body mass index 
(BMI) with suicide. However, it is uncertain whether the association is similar in 
non-Western settings and biological pathways underlying the association are unclear. 
We investigated these issues in a cohort of 542,088 Taiwanese aged 20 years or above 
(1994-2008) who participated in a health check-up program; there were 573 suicides 
over a mean 8.1 years follow-up. There was a J-shaped association of BMI with 
suicide risk (P for the quadratic term=0.033) but little evidence for a linear association; 
compared with individuals whose BMI was 18.5-22.9 kg/m2, adjusted hazard ratios 
for those with a BMI < 18.5 kg/m2 and >= 35 kg/m2 were 1.56 (95% confidence 
interval [CI]: 1.07, 2.28) and 3.62 (95% CI: 1.59, 8.22) respectively. High waist-hip 
ratio was associated with increased risk of suicide. There was some evidence for a 
reverse J-shaped association of systolic blood pressure and high-density lipoprotein 
cholesterol with suicide and an association of higher triglyceride level with increased 
suicide risk; these associations did not appear to mediate the associations of BMI and 
waist-hip ratio with suicide. There was little evidence for associations with fasting 
glucose, total cholesterol or low-density lipoprotein cholesterol.  
 
body mass index; cholesterol; cohort studies; suicide; systolic blood pressure; Taiwan; 
  3    
triglyceride; waist-hip ratio 
 
Abbreviations: BMI, body mass index; CI, confidence interval; HDL-C, high-density 
lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; 
PUFA, polyunsaturated fatty acid; SD, standard deviation 
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An emerging body of research indicates that body mass index (BMI, a measure 
of adiposity) is inversely associated with suicide risk. Greater BMI has been found to 
be related to a stepwise decreased risk of completed suicide in several large cohorts 
from Western nations including the UK (1), Sweden (2), Norway (3, 4) and the US 
(5-8). Similar associations with attempted suicide are also reported (9, 10). These 
associations are found across the whole range of BMI and persist after controlling for 
potential confounding factors such as socioeconomic position, smoking and alcohol 
use. Such findings are intriguing as obesity has been associated with stigma (11) and 
increased risk of depression (12), and depression is a well-established risk factor for 
suicide (13). With the exception of one recent Chinese study (14), analysis of the 
adiposity-suicide relationship has generally been restricted to Western settings.  
Biological mechanisms underlying the association of low BMI with suicide may 
involve metabolic consequences of adiposity such as insulin resistance, a syndrome 
associated with high BMI and raised levels of insulin and fatty acids. Increased blood 
levels of fatty acids may raise levels of circulating tryptophan, which may in turn 
increase brain serotonin (15), an important neurotransmitter associated with reduced 
impulsivity and suicidality (16). Suicide risk was found to decrease with increasing 
numbers of markers of insulin resistance such as high BMI, high systolic blood 
pressure and low high-density lipoprotein cholesterol in one Finnish study (17). It is 
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also postulated that lower circulating cholesterol levels, resulting from lower BMI, 
may reduce cerebral serotonin (18) and thus predispose to suicidal behaviours (19). 
While a number of studies have found an association of suicide risk with low blood 
cholesterol level, findings are inconsistent (20).  
To assess whether the association of adiposity with suicide is similar in 
non-Western settings and possible biological pathways underlying the association, we 
have investigated the risk of suicide in relation to a range of adiposity measures (BMI, 
waist circumstance and waist-hip ratio) and related physiological or biochemical 
changes (systolic blood pressure, fasting glucose, cholesterol and triglyceride) in a 
large sample of Taiwanese adults. 
 
MATERIALS AND METHODS 
Participants  
The study cohort consists of 542,088 Taiwanese adults aged 20 years or above 
who participated in a large health check-up program run by a private company (MJ 
Health Management Institution, Taiwan; https://www.mjclinic.com.tw) from 1994. 
Program participants undergo a series of physical examinations and biochemical tests 
using standardized procedures, as described elsewhere (21). Figure 1 shows a flow 
chart of the participants included in the study. The final numbers of the subsamples 
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that had complete information on potential confounders and were included in the 
multivariable analyses for i) BMI, ii) waist circumference and waist-hip ratio, iii) 
systolic blood pressure, fasting glucose, total cholesterol and triglyceride, and iv) 
high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol 
(LDL-C) were 408,075 (75.3% of the total cohort), 345,357 (63.7%), 406,610 (75.0%) 
and 377,056 (69.6%) respectively.  
Measurements of adiposity and related biological factors 
Participants were measured barefoot and wearing light clothes. Weight (to the 
nearest 0.1 kg) and height (to the nearest mm) were measured using an 
auto-anthropometer, Nakamura KN-5000A (Nakamura, Tokyo, Japan). Waist 
circumference (to the nearest mm) was measured at the midpoint between the lower 
end of rib cage and the crest of the ilium. Hip circumference (to the nearest mm) was 
measured around the pelvis at the point of maximal protrusion of the buttocks. Blood 
pressure on the right arm was measured twice at 10 min intervals, with the 
participants seated after a 5-min rest, using a computerized 
auto-mercury-sphygmomanometer, Citizen CH-5000 (Citizen, Tokyo, Japan); the 
mean of two measurements was used for the analysis. Fasting (overnight) blood was 
collected for the measurement of glucose, total cholesterol, HDL-C, LDL-C and 
triglyceride using the Hitachi 7150 auto-analyser (Hitachi, Tokyo, Japan). Study 
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participants had given written consent after complete description of the use of data 
collected from the health check-up for research. The study was approved by the 
National Health Research Institutes, Taiwan, and the MJ Health Management 
Institution. 
Ascertainment of suicide mortality 
Suicide deaths up to December 31, 2008 were obtained through linkage with 
Taiwan’s national cause-of-death register, using the International Classification of 
Diseases Ninth Revision codes E950-E959. Previous research indicates that, in 
keeping with findings seen in Western nations, many Taiwanese deaths coded as 
undetermined intent (E980-E989), accidental pesticide poisoning (E863) and 
accidental suffocation (E913) are likely to be misclassified suicides (22). We therefore 
included these deaths in our definition of suicide. In a sensitivity analysis we included 
certified suicides coded as E950-E959 only. 
Statistical analysis 
Sex-specific z scores for adiposity measures (BMI, waist circumstance and 
waist-hip ratio), systolic blood pressure and biochemical levels (fasting glucose, total 
cholesterol, HDL-C, LDL-C and triglyceride) were calculated as the number of 
standard deviations above (positive values) or below (negative values) the mean. BMI 
was also categorized into seven groups according to the World Health Organization 
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criteria (23), with additional cut-off points proposed for Asian populations (24) 
(underweight: <18.5; normal weight: 18.5-22.9 and 23.0-24.9; overweight: 25.0-26.9 
and 27.0-29.9; grade I obesity: 30.0-34.9; and grade II and III obesity: >=35), and 
other risk factors into quintiles.  
Cox proportional hazards models were used to investigate the association of 
adiposity and associated risk factors with suicide. Time at entry was the date of 
recruitment; time of exit was December 31, 2008 or the date of death if earlier. The 
proportional hazards assumption was assessed by plotting Schoenfeld residuals versus 
time and examining their correlation.  
We initially controlled for sex and age using the full sample. To test whether the 
associations differ by sex or age, we included interaction terms in the models. To 
investigate evidence for non-linear associations we performed likelihood ratio tests 
comparing models with and without the quadratic terms for z scores of variables 
investigated. We used multivariable models to investigate the effect on the association 
of simultaneously controlling for sex, age, marital status (single, married, divorced or 
separated, widowed), education (middle school or below, high school, junior college, 
college or higher), smoking (never, former, current), alcohol use (no or occasional use, 
former drinking, regular drinking), physical activity (inactive, low, moderate or high), 
history of diabetes and history of cancer. Information on these potential confounders 
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was obtained from the baseline questionnaire completed by participants. 
Severe mental illness and use of psychotropic drugs are associated with both 
suicide risk and weight loss/gain or metabolic abnormalities (e.g. high lipid levels) 
(25). To assess their possible impact on the associations of our exposures with suicide, 
we conducted two sensitivity analyses. First, in the subset of participants with data on 
medicine use we controlled for the use of psychotropic drugs in multivariable models. 
Second, in keeping with previous studies (2, 3) we excluded all suicides occurring in 
the first two years of follow-up as BMI in these participants was more likely to be 
influenced by any severe mental illness at baseline. All analyses in this study were 
conducted using SAS software, version 9.1 (SAS Institute). 
 
RESULTS 
Participant characteristics 
Among the total cohort of 542,088 participants we identified 573 certified or 
possible suicides (455 [79.4%] certified suicides, 104 [18.2%] deaths of undetermined 
intent, 9 [1.6%] accidental deaths by pesticide poisoning and 5 [0.9%] accidental 
deaths by suffocation) over an average 8.1-year follow-up period. The crude suicide 
rates were 16.2 and 10.4 per 100,000 person-years for males and females respectively. 
The mean age at baseline was 41.2 years for males and 41.1 years for females. 
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At baseline, mean BMI was 23.9 (standard deviation [SD] 3.4) kg/m2 for males 
and 22.1 (SD 3.6) kg/m2 for females; corresponding figures for waist circumference 
and waist-hip ratio were 82.3 (SD 9.2) cm and 0.86 (SD 0.07) for males and 71.6 (SD 
8.9) cm and 0.77 (SD 0.06) for females respectively. Overweight and obesity were 
more common in men than women – the proportions of males who were underweight, 
normal, overweight and obese were 4.1%, 61.9%, 29.8% and 4.3%; the corresponding 
figures for females were 12.0%, 66.7%, 17.7% and 3.6%.  
Compared with participants without information on socio-demographic and 
health-related factors, the 408,075 participants (356 certified or possible suicides) 
with these data were slightly younger (40.3 versus 43.3 years) and more likely to be 
male (49.4% versus 42.2%). Characteristics of the 408,075 participants are shown in 
Table 1. Underweight subjects and very obese males were younger than those in other 
BMI categories. Individuals with a high BMI were more likely to have lower 
educational levels (females) and diabetes than those with a lower BMI. The 
proportions of individuals who were current smokers, unmarried or physically 
inactive were highest at the high and low extremes of the BMI distributions. The 
prevalence of current smoking was high in male participants (40.6%) but low in 
females (6.7%). High BMI was associated with higher blood pressure, fasting glucose, 
total cholesterol, LDL-C and triglyceride but lower HDL-C. 
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Body mass index and suicide  
In sex- and age-adjusted models based on data for the total cohort, there was 
little evidence for a linear association of BMI z score with suicide risk (hazard ratio 
[HR]=0.94 per one SD increase, 95% confidence interval [CI]: 0.86, 1.02) (Table 2). 
There was evidence for a quadratic relationship (P for likelihood ratio test=0.033), in 
keeping with the finding of increased suicide risk in both underweight and extremely 
obese subjects (Table 2). There was no evidence for sex or age differences in 
associations of BMI with suicide (both P values for interaction > 0.10); in 
age-adjusted models HRs for suicide per one SD increase in BMI were 0.98 (95% CI: 
0.87, 1.10) for males and 0.88 (95% CI: 0.77, 1.03) for females.  
Associations were very similar in the subsample with information on 
confounders (Table 2). In separate sex- and age-adjusted analyses both current 
smoking (HR=2.16, 95% CI: 1.69, 2.76) and regular drinking (HR=1.78, 95% CI: 
1.30, 2.43) were associated with increased risk of suicide, but there was no strong 
evidence for interactions with BMI in relation to suicide risk (both P values for 
interaction > 0.10). Stratified analyses (fully adjusted) by smoking or drinking status 
showed somewhat weak evidence for an inverse association of BMI with suicide 
among smokers (HR=0.87, 95% CI: 0.73, 1.04) but not in non-/former smokers 
(HR=1.01, 95% CI: 0.87, 1.17); there was no strong evidence for a linear association 
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in regular drinkers (HR=0.94, 95% CI: 0.69, 1.27) or non-/occasional/former drinkers 
(HR=0.94, 95% CI: 0.84, 1.06). 
In the subsample with information on psychotropic drug use, sex- and 
age-adjusted analyses showed a strong association of this variable with suicide risk 
(HR=13.79, 95% CI: 8.43, 22.55); when further controlling for the use of 
psychotropic drugs, there was still limited evidence for a linear association of BMI 
with suicide (HR=0.92, 95% CI: 0.78, 1.07). Results were similar when excluding all 
suicides occurring in the first two years after baseline measurements or restricting 
analyses to certified suicides only (data not shown). 
Waist circumference, waist-hip ratio and suicide  
Waist circumference was not associated with risk of suicide; there was no 
evidence for an association in the total sample or the subsample with full information 
on socio-demographic and health-related variables (Table 2). Greater waist-hip ratio 
was associated with a higher suicide risk. In sex- and age-adjusted models based on 
the total cohort, HR per SD increase in waist-hip ratio was 1.04 (95% CI: 1.01, 1.07). 
This association did not differ by sex, age, smoking or drinking status (all P values for 
interaction > 0.10). When we examined associations using quintiles, there appeared to 
be a threshold effect, with increased suicide risk only clearly increasing in those in the 
top two quintiles and statistical evidence for a curvilinear association (P for likelihood 
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ratio test comparing the model with a quadratic term to that without=0.018). Results 
were similar in the subset of participants with full information on confounders. 
Results remained unchanged in sensitivity analyses further adjusting for psychotropic 
drug use or excluding all suicides occurring in the first two years of follow-up, as well 
as in analyses based on certified suicides only (data not shown). 
Biological factors related to adiposity and suicide 
There was no evidence for a linear association of suicide risk with systolic blood 
pressure (Table 3), although there was evidence for a quadratic relationship (P for 
likelihood ratio test=0.005), with increased risk towards the extremes of systolic 
blood pressure distributions (a reverse J-shaped association). Fasting glucose was not 
associated with suicide risk in the total sample when adjusting for sex and age; in the 
subsample with information on confounders there was weak evidence for an 
association of higher glucose with lower suicide risk (fully adjusted HR per SD 
increase=0.90, 95% CI: 0.80, 1.03). There was no evidence for an association of 
suicide risk with total cholesterol, while there was some evidence for a quadratic 
relationship between HDL-C and suicide, with increased suicide risk towards the two 
ends of the HDL-C distribution (P for likelihood ratio test=0.039). There was limited 
evidence for an association of LDL-C with suicide risk.  
In the sex- and age-adjusted model for the total sample, higher triglyceride was 
  14    
associated with greater suicide risk (HR per SD increase=1.08, 95% CI: 1.03, 1.13). 
When restricting to participants with information on potential confounders, this 
association was similar in the sex- and age-adjusted model but somewhat attenuated 
after adjusting for potential confounders (HR=1.06, 95% CI: 0.99, 1.13). In a 
sensitivity analysis further controlling for psychotropic drug use, the association was 
similar (HR=1.07, 95% CI: 0.98, 1.17). Individuals in the highest quintile of 
triglyceride had 28-44% increased risk of suicide compared to those in the lowest 
quintile.  
When assessing the impact of controlling for systolic blood pressure, HDL-C and 
triglyceride, given the evidence for their associations with suicide, we found similar 
associations of BMI/waist-hip ratio with suicide when controlling for each of the three 
biological markers respectively (data not shown). 
 
DISCUSSION 
In contrast to the linear inverse association of BMI with suicide in several 
Western cohorts (1-8), we found only limited evidence of such a relationship in this 
Taiwanese study. Suicide risks were increased in both underweight and extremely 
obese individuals. There was also evidence for quadratic relationships of waist-hip 
ratio, systolic blood pressure and HDL-C with suicide. Greater triglyceride levels 
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were associated with a higher risk of suicide. The associations of systolic blood 
pressure, HDL-C and triglycerides with suicide did not appear to mediate the 
associations of BMI and waist-hip ratio with suicide. We found limited evidence that 
waist circumference, fasting glucose, total cholesterol or LDL-C were associated with 
suicide.  
Strengths and limitations 
This study, to the best of our knowledge, is the first large cohort study to 
investigate the association of a range of adiposity measures and related biological 
markers with risk of suicide in a non-Western setting. Anthropometric data were 
measured using standardized procedures as part of a comprehensive health check. The 
study has several limitations. First, associations could be confounded by unmeasured 
factors; for example, we had no detailed information on psychiatric morbidity (e.g. 
depression), although associations were similar in models controlling for a proxy 
indicator of psychiatric disorders (i.e. psychotropic drug use). Second, adiposity and 
related biological markers were measured once only at the baseline assessment – 
repeated measures of these factors and psychiatric morbidity may provide further 
information on their relationships with suicide. Third, the cohort was derived from a 
privately run health check-up program. However, the prevalence of obesity and other 
characteristics such as smoking in this cohort was similar to that shown in a national 
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survey in 2000-2001 (26, 27), although suicide rates in this cohort were slightly lower 
than those for Taiwan’s population (8.4 versus 11.9 per 100,000, age-standardized 
rates) (28). 
Association of adiposity with suicide 
We found an increased risk of suicide in both underweight and extremely obese 
individuals. A recent study of British male government employees also showed 
increased suicide risk in obese men (BMI>=30) (29), although evidence for increased 
suicide risk in individuals with obesity/extreme obesity remains to be firmly 
established because there were few suicides in the obese in the British study (n=6) or 
the very obese group in our study (n=6). Unlike findings from several large cohort 
studies in Western countries (1-8), we did not find that suicide risk decreased linearly 
from low to high BMI, although the 95% confidence interval estimates of the 
association with BMI from our study overlapped those reported in previous research - 
in one Norwegian cohort the hazard ratio for suicide was estimated to be 0.82 (95% 
CI: 0.68, 0.98) per one SD increase in BMI (3) while our estimate based on the total 
cohort was 0.94 (95% CI: 0.86, 1.02).  
It is possible that the obesity-suicide association differs in Western and 
non-Western settings, although a recent cohort study of 170,000 Chinese adults found 
some evidence of an inverse association of BMI with suicide (14). If our study 
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findings do signal a difference in associations between Asian and Western settings 
possible explanations include differing cultural attitudes towards body size and 
dietary differences. In traditional Chinese culture thinness is associated with poverty, 
misfortune and poor health, while a certain degree of ‘fullness’ symbolizes prosperity 
and longevity (30), in contrast to the Western pattern of attitudes towards body size. 
One dietary factor, the polyunsaturated fatty acids (PUFAs), has been linked to 
decreased risk of depression and suicidal ideation (31), and a recent study showed that 
the Taiwanese population had the highest percentage (% of total dietary energy intake) 
of PUFAs among 28 countries investigated (32). However, one US study found that 
the inverse association of BMI with suicide persisted after controlling for dietary 
omega-3 fatty acids, an important type of PUFAs (7).  
Our finding that greater waist-hip ratio is associated with greater suicide risk 
differs from one previous US study that found weak evidence for higher suicide risk 
in men with lower values of self-reported waist-hip ratios (7). In the absence of other 
studies of this association it remains unclear what the true association of waist-hip 
ratio is with suicide risk.  
Association of biological markers of adiposity with suicide 
In general, beyond studies of the associations of BMI/cholesterol with suicide 
there are few studies investigating other markers of adiposity, or adiposity related 
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mediators, in relation to suicide risk. Of the range of potential mediators that we 
examined only three related to suicide risk – systolic blood pressure and HDL-C with 
a reverse J-shaped association and triglyceride with a positive association – but 
controlling for these factors in multivariable models indicated that they did not 
mediate associations of adiposity with suicide. Findings from previous studies of the 
relationship between blood pressure and suicide are inconsistent (17, 33-35). To our 
knowledge no previous study has investigated the association of triglyceride with risk 
of completed suicide; the small number of studies that have examined its association 
with suicide attempts have produced inconsistent findings (36-40).  
Our finding of no evidence for an association of total cholesterol with suicide 
risk is consistent with a meta-analysis of 19 randomized control trials, which reported 
no relation of cholesterol lowering treatments and non-illness mortality (including 
suicide and accident) (41). Our finding that fasting glucose is not associated with 
suicide risk is also consistent with one previous study (33).  
Possible explanations for associations 
This association of underweight with suicide risk may be confounded by 
psychopathology such as anorexia nervosa that is related to both low body weight and 
increased risk of suicide (42). As discussed earlier, it is also possible that 
physiological changes associated with low body weight, including low circulating 
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fatty acids, may influence neurotransmitter level which in turn affects impulsivity and 
suicide risk (17), but we found no evidence that lower levels of fasting glucose, 
cholesterol or triglyceride were associated with increased risk. Indeed higher 
triglyceride levels were associated with increased risk. 
Increased abdominal fat, indicated by high waist-hip ratios, has been found to 
be associated with heightened cortisol elevations in response to stress (43) and 
depressive symptoms (44) and may lead to increased suicide risk. Alternatively, use of 
certain psychotropic drugs (e.g. some antipsychotics) may result in greater waist-hip 
ratios (45) and explain an association with suicide. However, our results remained 
unchanged when controlling for psychotropic drug use. 
One biological factor that may contribute to the association of high triglyceride 
with increased suicide risk, as mentioned earlier, is dietary PUFAs, which have been 
found to be associated with both reduced triglyceride level (46) and reduced risk of 
having suicidal ideation (31). Another possible underlying mechanism is hyperactivity 
of the hypothalamic-pituitary-adrenocortical axis; increased circulating cortisol level 
has been linked to both hypertriglyceridemia (47) and depression (48), although its 
other related physiological effects such as hypercholesterolemia and hypertension 
were not found to be associated with suicide risk in our study. 
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Implications 
Our study indicates that associations of adiposity with suicide risk may differ in 
Asian populations from those observed in the West. A better understanding of the 
complex interactions between adiposity, its related biological factors and suicide may 
pave the way to new findings about the causes of suicide and, possibly, novel targets 
for intervention and drug development.  
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FIGURES 
Figure 1. Flow chart of participants of the MJ health check-up program, Taiwan, 
1994-2008 (N = 542,088). From 1996 the program included a self-completed 
questionnaire to collect baseline information on socio-demographic and health-related 
factors. From 1998 the questionnaire added in questions on the use of medications, 
including psychotropic drugs. Subsamples of the participants were used in the sex and 
age-adjusted analyses (A), main multivariable analyses (B) and sensitivity analyses 
additionally controlling for psychotropic drug use (C).  
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TABLES 
Table 1. Characteristics of the Participants With Socio-demographic and Health-related Information, According to Body Mass Index Categories 
(n = 408,075), MJ Health Check-up Program, Taiwan, 1994-2008. 
  Body mass index categories (kg/m2) All participants 
Characteristic <18.5 18.5-22.9 23.0-24.9 25.0-26.9 27.0-29.9 30.0-34.9 >=35.0 (by sex) 
Males (n = 8,062) (n = 74,604) (n = 50,631) (n = 36,191) (n = 23,449) (n = 7,612) (n = 1,101) (n = 201,650) 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age (years) 36.8  14.7  38.7  13.7  41.5  13.3  42.7  13.1  42.3  12.9  39.5  12.4  35.0  10.6  40.5  13.5  
Systolic blood pressure (mmHg)a 114.9  15.3  119.5  15.9  123.2  16.5  126.1  17.1  129.0  17.2  132.3  17.5  136.7  17.7  123.1  17.0  
Fasting glucose (mg/dl)a 95.0  19.6  98.1  21.5  101.0  22.2  103.3  24.3  105.3  25.9  107.8  29.7  108.9  28.6  100.9  23.3  
Total cholesterol (mg/dl)a 177.5  34.1  188.5  35.8  198.2  36.4  202.5  37.2  205.1  37.8  206.1  39.3  203.9  37.3  195.7  37.3  
HDL cholesterol (mg/dl)a 55.0  14.5  49.5  13.2  45.6  12.1  43.7  11.4  42.4  10.9  41.6  10.5  40.9  10.1  46.5  12.7  
LDL cholesterol (mg/dl)a 107.0  30.5  118.5  32.0  125.9  32.1  128.3  32.6  128.7  33.1  127.2  33.1  125.9  31.5  123.2  32.7  
Triglyceride (mg/dl)a 79.9  49.8  106.1  81.1  141.0  111.3  164.7  138.5  187.0  153.2  206.4  190.2  204.5  172.3  138.1  120.3  
 N % N % N % N % N % N % N % N % 
Married 4,263  52.9  46,461  62.3  37,363  73.8  28,146  77.8  18,031  76.9  5,268  69.2  588  53.4  140,120  69.5  
College or higher education 2,496  31.0  27,711  37.1  18,967  37.5  12,722  35.2  7,830  33.4  2,614  34.3  405  36.8  72,745  36.1  
Current smoker 3,746  46.5  30,016  40.2  19,694  38.9  14,493  40.0  9,744  41.6  3,322  43.6  510  46.3  81,525  40.4  
Regular alcohol use 707  8.8  7,483  10.0  5,539  10.9  4,285  11.8  2,861  12.2  793  10.4  80  7.3  21,748  10.8  
Physically inactive 4,488  55.7  34,091  45.7  22,251  43.9  16,289  45.0  11,209  47.8  3,841  50.5  624  56.7  92,793  46.0  
History of diabetes 154  1.9  2,453  3.3  2,488  4.9  2,509  6.9  2,100  9.0  881  11.6  152  13.8  10,737  5.3  
History of cancer 77  1.0  472  0.6  252  0.5  203  0.6  100  0.4  30  0.4  5  0.5  1,139  0.6  
Use of psychotropic drugsb 58  1.0  397  0.7  217  0.6  151  0.6  105  0.6  39  0.6  5  0.5  972  0.6  
                 
Females (n = 27,239) (n = 107,774) (n = 31,437) (n = 19,413) (n = 13,868) (n = 5,767) (n = 927) (n = 206,425) 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age (years) 31.2  9.3  37.4  12.0  45.9  13.6  48.8  13.5  50.0  13.3  48.8  13.9  44.3  14.1  40.1  13.6  
Systolic blood pressure (mmHg)a 107.1  13.4  112.0  16.6  122.3  21.1  127.6  21.9  131.7  22.1  135.1  22.1  137.7  21.3  116.4  19.9  
Fasting glucose (mg/dl)a 90.8  11.4  94.1  17.0  100.2  24.7  103.3  28.3  106.9  31.8  110.1  34.7  112.6  35.4  96.8  21.7  
Total cholesterol (mg/dl)a 178.3  31.7  187.1  34.9  199.8  39.0  204.8  39.5  207.4  39.5  208.1  39.1  207.5  40.9  191.6  37.3  
HDL cholesterol (mg/dl)a 63.8  15.3  59.0  15.1  54.0  14.5  51.7  13.9  50.4  13.4  49.2  12.9  48.0  12.2  57.2  15.3  
LDL cholesterol (mg/dl)a 101.2  28.1  112.0  31.0  123.6  33.9  127.7  34.5  129.2  34.1  129.6  34.2  129.1  35.4  115.7  33.0  
Triglyceride (mg/dl)a 66.1  28.5  82.7  54.0  116.2  91.2  132.7  97.7  146.7  105.8  153.8  104.8  160.1  106.0  96.9  74.7  
 N % N % N % N % N % N % N % N % 
Married 12,107  44.4  67,021  62.2  22,650  72.0  14,171  73.0  10,058  72.5  3,974  68.9  538  58.0  130,519  63.2  
College or higher education 10,712  39.3  33,685  31.3  5,428  17.3  2,443  12.6  1,386  10.0  521  9.0  117  12.6  54,292  26.3  
Current smoker 2,712  10.0  7,377  6.8  1,628  5.2  892  4.6  695  5.0  356  6.2  78  8.4  13,738  6.7  
Regular alcohol use 475  1.7  1,814  1.7  545  1.7  341  1.8  210  1.5  96  1.7  13  1.4  3,494  1.7  
Physically inactive 18,593  68.3  63,093  58.5  16,619  52.9  10,333  53.2  7,783  56.1  3,419  59.3  629  67.9  120,469  58.4  
History of diabetes 179  0.7  2,216  2.1  1,926  6.1  1,663  8.6  1,663  12.0  909  15.8  178  19.2  8,734  4.2  
History of cancer 198  0.7  1,455  1.4  677  2.2  492  2.5  393  2.8  139  2.4  19  2.0  3,373  1.6  
Use of psychotropic drugsb 139  0.6  614  0.7  255  1.1  150  1.1  116  1.2  50  1.2  11  1.6  1,335  0.9  
Abbreviation: SD, standard deviation. 
aIn the subsample with information on biochemical tests (n = 200,915 for males and 205,695 for females, except n = 184,2824 for males and 192,774 for females for HDL-C and LDL-C). 
bIn the subsample with information of the use of psychotropic drugs (n = 150,515 for males and 155,326 for females). 
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Table 2. Hazard Ratio for Suicide by Body Mass Index (According to the WHO Classification and per SD Increase), Waist Circumference and 
Waist-hip Ratio (in Sex-specific Quintiles and per SD Increase), MJ Health Check-up Program, Taiwan, 1994-2008. 
  Total cohorta       Subsample with confounder informationa 
 
Number of 
participants 
Number 
of 
suicides 
Adjusted for sex and age   
Number of 
participants 
Number of 
suicides 
Adjusted for sex and age   Multivariable adjustmentb  
Covariates 
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value 
Body mass indexc                      
<18.5 44,545  47 1.40   1.02 , 1.93   35,301  35 1.62   1.11 , 2.36   1.56   1.07 , 2.28  
18.5-22.9 239,050  229 1.00   Reference   182,378  139 1.00   Reference   1.00   Reference  
23.0-24.9 110,022  127 0.99   0.80 , 1.24   82,068  86 1.14   0.87 , 1.51   1.18   0.89 , 1.55  
25.0-26.9 75,733  90 0.97   0.76 , 1.25   55,604  48 0.90   0.65 , 1.26   0.91   0.65 , 1.28  
27.0-29.9 51,406  55 0.88   0.66 , 1.19   37,317  31 0.88   0.59 , 1.31   0.87   0.58 , 1.29  
30.0-34.9 18,581  19 0.94   0.59 , 1.50   13,379  11 0.97   0.52 , 1.79   0.91   0.49 , 1.70  
>=35.0 2,751  6 2.42   1.08 , 5.43   2,028  6 4.15   1.83 , 9.39   3.62   1.59 , 8.22  
 Per standard deviation (sex-specific) 0.94   0.86 , 1.02 0.14f     0.95   0.85 , 1.06 0.35f   0.95   0.85 , 1.06 0.35f  
   P for quadratic term 0.033g         0.013g      0.050g 
Waist circumference in quintilesd                     
Quintile 1 70,637  61 1.00   Reference   63,448  50 1.00   Reference   1.00   Reference  
Quintile 2 67,721  43 1.58   1.07 , 2.35   60,294  35 1.33   0.88 , 2.02   1.25   0.82 , 1.89  
Quintile 3 81,761  46 1.24   0.82 , 1.89   72,199  44 1.05   0.67 , 1.63   1.03   0.66 , 1.61  
Quintile 4 81,580  62 1.24   0.84 , 1.82   71,015  50 1.06   0.71 , 1.60   1.04   0.70 , 1.57  
Quintile 5 91,187  93 1.42   0.99 , 2.04   78,401  83 1.37   0.94 , 2.00   1.30   0.89 , 1.89  
 Per standard deviation (sex-specific) 1.02   0.91 , 1.15 0.74f     1.09   0.96 , 1.23 0.20f   1.08   0.95 ,1.22 0.25f  
   P for quadratic term 0.063g        0.11g      0.24g 
Waist-hip ratio in quintilese                      
Quintile 1 56,203  32 1.00   Reference   50,634  27 1.00   Reference   1.00   Reference  
Quintile 2 76,484  45 1.03   0.65 , 1.63   68,407  38 1.03   0.63 , 1.70   1.01   0.62 , 1.67  
Quintile 3 77,819  47 1.02   0.64 , 1.62   68,757  39 1.02   0.62 , 1.69   1.00   0.60 , 1.65  
Quintile 4 88,478  77 1.34   0.86 , 2.07   77,307  67 1.43   0.89 , 2.30   1.36   0.85 , 2.19  
Quintile 5 93,902  104 1.40   0.89 , 2.18   80,252  91 1.55   0.96 , 2.51   1.37   0.84 , 2.23  
 Per standard deviation (sex-specific) 1.04   1.01 , 1.07 0.022 f     1.04   1.01 , 1.07 0.013f   1.04   1.00 ,1.07 0.045f  
      P for quadratic term 0.018g                0.008g           0.041g  
Abbreviation: SD, standard deviation; WHO, World Health Organization. 
aN = 542,088 for total cohort and n = 408,075 for subsample (body mass index) and n = 392,886 for total cohort and 345,357 for subsample (waist-hip ratio and waist circumference). 
bMultivariable adjustments for sex, age, education, marital status, smoking, frequency of alcohol use, physical activity, diabetes history and cancer history. 
cSex-specific quintiles of body mass index (kg/m2): males (<21.1, 21.1-22.9, 23.0-24.7, 24.8-26.6, >=26.7) and females (<19.3, 19.3-21.3, 21.4-23.2, 23.3-25.4, >=25.5). 
dSex-specific quintiles of waist circumference (cm): males (<74.8, 74.8-78.9, 79.0-83.9, 84.0-88.9, >=89.0) and females (<64.0, 64.0-67.9, 68.0-71.9, 72.0-77.9, >=78.0). 
eSex-specific quintiles of waist-hip ratio: males (<0.80, 0.80-0.83, 0.84-0.86, 0.87-0.90, >=0.91) and females (<0.71, 0.71-0.73, 0.74-0.76, 0.77-0.80, >=0.81). 
fP value for the linear associations of adiposity measures (body mass index, waist circumference and waist-hip ratio) with suicide (i.e. tests of linear trends), derived by including these adiposity 
measures as continuous variables (i.e. using their z scores) in the models. 
gP value of likelihood ratio test comparing the goodness of fit of models with and without the quadratic term of the continuous z score. Small P value indicates quadratic relationship. 
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Table 3. Hazard Ratio for Suicide by Systolic Blood Pressure, Fasting Glucose, Total Cholesterol, Triglyceride, High-density Lipoprotein 
Cholesterol and Low-density Lipoprotein Cholesterol (in Quintiles and per Standard Deviation Increase), MJ Health Check-up Program, Taiwan, 
1994-2008. 
  Total cohort (n = 537,620)     Subsample with confounder information (n = 406,610) 
 
Number of 
participants 
Number 
of 
suicides 
Adjusted for sex and age  
Number of 
participants 
Number of 
suicides 
Adjusted for sex and age  Multivariable adjustmenta 
Covariates 
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value 
Systolic blood pressure in quintilesb                     
Quintile 1 110,524  139 1.00   Reference   84,218  87 1.00   Reference   1.00   Reference  
Quintile 2 108,582  109 0.85   0.66 , 1.09   84,672  68 0.81   0.59 , 1.12   0.84   0.61 , 1.16  
Quintile 3 109,380  84 0.61   0.47 , 0.80   84,689  56 0.63   0.45 , 0.89   0.66   0.47 , 0.92  
Quintile 4 99,384  89 0.65   0.50 , 0.86   75,514  51 0.60   0.42 , 0.85   0.62   0.43 , 0.88  
Quintile 5 109,750  151 0.75   0.58 , 0.98   77,517  94 0.81   0.59 , 1.13   0.83   0.60 , 1.16  
 Per standard deviation (sex-specific)  0.95   0.87 , 1.04 0.25f     1.00   0.90 , 1.12 0.96f   1.01   0.90 , 1.13 0.87f  
   P for quadratic term 0.005g         0.001g      0.002g 
Fasting glucose in quintilesc                     
Quintile 1 116,391  151 1.00   Reference   85,291  91 1.00   Reference   1.00   Reference  
Quintile 2 99,942  96 0.78   0.60 , 1.00   76,377  57 0.71   0.51 , 0.99   0.74   0.53 , 1.03  
Quintile 3 115,161  118 0.82   0.64 , 1.04   89,623  79 0.82   0.61 , 1.11   0.87   0.64 , 1.18  
Quintile 4 104,168  92 0.71   0.55 , 0.93   80,151  62 0.72   0.52 , 1.00   0.77   0.55 , 1.06  
Quintile 5 101,958  115 0.78   0.60 , 1.01   75,168  67 0.70   0.50 , 0.98   0.73   0.52 , 1.02  
 Per standard deviation (sex-specific)  0.97   0.89 , 1.05 0.46f     0.90   0.79 , 1.03 0.14f   0.90   0.80 , 1.03 0.12f  
   P for quadratic term 0.42g         0.41g      0.33g 
Total cholesterol in quintilesd                      
Quintile 1 110,888  127 1.00   Reference   78,603  69 1.00   Reference   1.00   Reference  
Quintile 2 105,503  111 0.92   0.71 , 1.19   79,566  63 0.86   0.61 , 1.21   0.88   0.62 , 1.24  
Quintile 3 107,906  93 0.73   0.56 , 0.96   82,890  66 0.82   0.59 , 1.16   0.84   0.59 , 1.18  
Quintile 4 108,063  129 0.98   0.76 , 1.25   83,582  77 0.89   0.64 , 1.25   0.91   0.65 , 1.27  
Quintile 5 105,260  112 0.80   0.61 , 1.04   81,969  81 0.85   0.60 , 1.19   0.85   0.61 , 1.19  
 Per standard deviation (sex-specific)  0.97   0.89 , 1.05 0.41f     0.97   0.87 , 1.08 0.59f   0.97   0.87 , 1.08 0.54f  
   P for quadratic term 0.15g         0.40g      0.54g 
Triglyceride in quintilese                      
Quintile 1 107,842  91 1.00   Reference   84,060  55 1.00   Reference   1.00   Reference  
Quintile 2 109,128  104 1.03   0.78 , 1.36   83,657  68 1.12   0.79 , 1.60   1.10   0.77 , 1.57  
Quintile 3 105,924  93 0.90   0.67 , 1.20   80,408  62 1.01   0.70 , 1.45   0.97   0.67 , 1.40  
Quintile 4 107,122  128 1.17   0.89 , 1.54   79,968  74 1.15   0.81 , 1.65   1.09   0.76 , 1.57  
Quintile 5 107,604  156 1.33   1.01 , 1.74   78,517  97 1.44   1.02 , 2.03   1.28   0.90 , 1.81  
 Per standard deviation (sex-specific)  1.08   1.03 , 1.13 0.001f     1.08   1.02 , 1.15 0.007f   1.06   0.99 , 1.13 0.087f  
      P for quadratic term 0.15g                0.25g           0.47g  
aMultivariable adjustments for sex, age, education, marital status, smoking, frequency of alcohol use, physical activity, diabetes history and cancer history. 
bSex-specific quintiles of systolic blood pressure (mmHg): males (<=109, 110-117, 118-126, 127-136, >136) and females (<=100, 101-109, 110-118, 119-132, >132). 
cSex-specific quintiles of fasting glucose (mg/dl): males (<=90, 91-94, 95-99, 100-105, >105) and females (<=87, 88-91, 92-95, 96-101, >101). 
dSex-specific quintiles of total cholesterol (mg/dl): males (<=163, 164-182, 183-200, 201-223, >223) and females (<=160, 161-178, 179-196, 197-220, >220). 
eSex-specific quintiles of triglyceride (mg/dl): males (<=71, 72-95, 96-126, 127-179, >179) and females (<=54, 55-70, 71-90, 91-128, >128). 
fP value for the linear associations of biological markers (systolic blood pressure, fasting glucose, total cholesterol, triglyceride, HDL cholesterol and LDL cholesterol) with suicide (i.e. tests of linear 
trends), derived by including these biological markers as continuous variables (i.e. using their z scores) in the models. 
gP value of likelihood ratio test comparing the goodness of fit of models with and without the quadratic term of the continuous z score. Small P value indicates quadratic relationship. 
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Table 3. Continued 
  Total cohort (n = 437,368)     Subsample with confounder information (n = 377,056) 
 
Number of 
participants 
Number 
of 
suicides 
Adjusted for sex and age  
Number of 
participants 
Number of 
suicides 
Adjusted for sex and age  Multivariable adjustmenta 
  
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value   
Hazard 
ratio   95% CI P value 
HDL cholesterol in quintilesh                                           
Quintile 1 89,880  120 1.00   Reference   75,003  100 1.00   Reference   1.00   Reference  
Quintile 2 86,642  89 0.97   0.74 , 1.28   74,160  73 0.94   0.69 , 1.27   0.97   0.72 , 1.32  
Quintile 3 89,872  66 0.78   0.58 , 1.06   77,853  52 0.72   0.51 , 1.00   0.75   0.53 , 1.05  
Quintile 4 86,902  69 0.93   0.69 , 1.25   75,893  59 0.92   0.66 , 1.27   0.97   0.70 , 1.34  
Quintile 5 84,072  63 0.93   0.68 , 1.26   74,147  52 0.88   0.63 , 1.23   0.91   0.64 , 1.27  
Per standard deviation (sex-specific)  0.97   0.88 , 1.07 0.56f     0.94   0.84 , 1.06 0.31f   0.96   0.86 , 1.07 0.42f  
    P for quadratic term 0.039g         0.022g       0.034g  
LDL cholesterol in quintilesi                      
Quintile 1 89,423  81 1.00   Reference   78,594  66 1.00   Reference   1.00   Reference  
Quintile 2 86,647  75 0.84   0.61 , 1.15   75,524  66 0.91   0.65 , 1.28   0.94   0.67 , 1.32  
Quintile 3 88,313  69 0.69   0.50 , 0.95   76,289  58 0.72   0.51 , 1.03   0.76   0.53 , 1.08  
Quintile 4 87,577  92 0.84   0.62 , 1.14   74,768  74 0.86   0.61 , 1.21   0.90   0.64 , 1.26  
Quintile 5 85,440  90 0.74   0.54 , 1.01   71,909  72 0.76   0.54 , 1.08   0.80   0.56 , 1.13  
Per standard deviation (sex-specific)  0.91   0.83 , 1.01 0.080d     0.94   0.84 , 1.05 0.24f   0.95   0.85 , 1.06 0.33f  
      P for quadratic term 0.26g                0.36g            0.54g  
Abbreviation: HDL, high-density lipoprotein; LDL, low-density lipoprotein. 
hSex-specific quintiles of HDL cholesterol (mg/dl): males (<=36, >36-<=42, >42-<=48, >48-<=56, >56) and females (<=43, >43-<=51, >51-<=59, >59-<=69, >69). 
iSex-specific quintiles of LDL cholesterol (mg/dl): males (<=96, >96-<=113, >113-<=129, >129-<=149, >149) and females (<=89, >89-<=105, >105-<=121, >121-<=142, >142). 
 
 
 
 
 
 
 
 
 
 
 
 
 
